1 / 4

In Vitro Diagnostic

In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027<br>According to this latest publication from Meticulous Researchu00ae, the IVD reagents market is expected to grow at a CAGR of 7% from 2020 to reach $77.6 billion by 2027. The high growth of the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research s

amey3
Download Presentation

In Vitro Diagnostic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. In Vitro Diagnostic (IVD) Reagents Market Worth $77.6 Billion by 2027 According to this latest publication from Meticulous Research®, the IVD reagents market is expected to grow at a CAGR of 7% from 2020 to reach $77.6 billion by 2027. The high growth of the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies. Moreover, the growing demand for protein therapeutics and personalized medicines and emerging economies offer significant growth opportunities for the players operating in this market. However, the unfavorable restrictions on approval procedure is expected to hamper the growth of the IVD reagents market to some extent. The global IVD reagents market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027- by type (oligonucleotide, antibodies, nucleic acid probe), technology (immunoassay, hematology, microbiology), use (research, analyte specific reagent), end user (IVD manufacturer, clinical laboratory), and geography. The study also evaluates industry competitors and analyzes the market at a country level. Based on type, the antibodies segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period. The fast growth of this segment is mainly attributed to the factors such as advancements in the field of genomics research, growing adoption of custom oligonucleotides, and rising strategic developments such as agreements and collaborations to expand oligonucleotides market. Based on use, the research use segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the clinical use segment is expected to grow with the fastest CAGR during the forecast period, mainly due to the factors such as rising adoption of advanced diagnostic modalities, growing importance of early disease diagnosis, number of diagnostic product launches, and demand for innovative reagents and assays for clinical usage. Based on end user, the IVD manufacturers segment is estimated to command the largest share of the overall IVD reagents market in 2020. The factors such as rising number of research activities for the development of innovative IVDs, growing public and private funds, and rising demand for advanced disease diagnostics are expected to drive the growth of the IVD reagents market for IVD manufacturing during the forecast period. Moreover, the recent outbreak of COVID-19 is also expected to support the growth of the IVD reagents market for this segment. However, the clinical laboratories segment is expected to register the highest growth during the forecast period. Geographic Review:

  2. This research report analyzes major geographies and provides comprehensive analysis for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is estimated to dominate the global IVD reagents market in 2020, followed by Europe and Asia Pacific. The factors such as growing healthcare sector, increasing need to treat various infectious diseases in early stage, increasing healthcare expenditure, and growing investments in personalized medicine and development of novel advanced technologies for diagnosis are supporting the largest share of North America in the global IVD reagents market. ??????????????:https://www.meticulousresearch.com/speak-to- analyst/cp_id=5110?utm_source=prodyuct&utm_medium=Social&utm_campaign=Product&utm_co ntent=15-12-2022 Key Players The report includes competitive landscape based on the extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by the leading market players in the industry over the past 4 years (2017-2020). The key players profiled in the global IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China). Scope of the Report: IVD Reagents Market, by Technology Immunoassay/Immunochemistry Enzyme-Linked Immunosorbent Assays (Elisa) Western Blotting Immunofluorescence Immunohistochemistry Functional Assays Immunoprecipitation Other Technologies Biochemistry/Clinical Chemistry Molecular Diagnostics Microbiology

  3. Hematology Coagulation/Hemostatis Urinalysis Other Technologies (Other Technologies comprises of hybridization and loop-mediated isothermal amplification among others) IVD Reagents Market, by Type Antibodies Antibodies Market, By Type Monoclonal Polyclonal Antibodies Market, By Target CD TCR EGFR Other Targets Oligonucleotides Nucleic Acid Probes Purified Proteins or Peptides Other Reagents (Other reagents include Blocking Agents, Detergents, Surfactants, Wetting Agents, Buffers, Stabilizers, Purified Water, Dyes, Standards & Controls, Enzymes, Cell Culture Reagents, and Anti- coagulants) IVD Reagents Market, by Use Research Use Only Analyte Specific Reagents Clinical Use IVD Reagents Market, by End User IVD Manufacturers

  4. Reference Laboratories Academic and Research Institutes Hospital Laboratories IVD Reagents Market, by Geography North America U.S. Canada Europe Germany Italy France U.K. Spain Rest of Europe (RoE) Asia-Pacific (APAC) Japan China India Rest of Asia Pacific (RoAPAC) Latin America Middle East & Africa ???????????????????? @https://www.meticulousresearch.com/download-sample- report/cp_id=5110?utm_source=prodyuct&utm_medium=Social&utm_campaign=Product&utm_co ntent=15-12-2022

More Related